MES-CoBraD is a success story on the EU Research & Innovation portal - @EUScienceInnov, covering the platform's role in diagnosis and its findings on sleep, AI ethics and earlier interventions.
mes-cobrad.eu/node/106
#H2020 #HorizonEU #MESCoBraD #BrainDisorders #Science4EU
Discover how the #EUfunded @MESCoBraD project is using emerging technologies to translate big data into new ways to better diagnose and manage complex brain disorders.
Read the article here 👉 projects.research-and-innova…
#ResearchImpactEU #Science4EU
This year's World Brain Day is the first one after the completion of the MES-CoBraD project! Our work and accomplishments were outlined in a new article posted by @EU_HaDEA.
Read more here: mes-cobrad.eu/node/105
#H2020 #HorizonEU #MESCoBraD #HealthcareInnovation #BrainDisorders
🧠 On today's #WorldBrainDay, discover #EUfunded projects managed by HaDEA contributing to improving the quality of life of millions of EU citizens living with brain disorders.
Learn more: hadea.ec.europa.eu/news/worl…
#H2020 #HorizonEU
H2020MESCoBraD retweeted
👏#Athens becomes the first city in Europe to eliminate municipal fees for energy-poor households! Introduced by Mayor @h_doukas, this groundbreaking initiative directly alleviates financial burdens on those affected by energy poverty.
Read⬇️netzerocities.eu/2024/12/16/…
#MissionCities
The #MESCoBraD project’s final webinar is almost here! Discover key takeaways & insights from top experts after 3 years of research insights and advancements. Click on the link below to register!
#MESCoBraD #BrainHealth
🗓️ 06/12/2024
🕒 11:00 CET
🔗 mes-cobrad.eu/Key-Insights-f…
🚨Attention #RDM, #AI, & #DataScience enthusiasts!
For the last 3,5 years, LIBER has participated in @MESCoBraD. As this innovative project comes to a close, join us for the final webinar & learn about future of brain disorder research.
Don't miss out!👉ow.ly/FOBe50U6TXp
H2020MESCoBraD retweeted
🚨Attention #RDM, #AI, & #DataScience enthusiasts!
For the last 3,5 years, LIBER has participated in @MESCoBraD. As this innovative project comes to a close, join us for the final webinar & learn about future of brain disorder research.
Don't miss out!👉ow.ly/FOBe50U6TXp
Want to know how #MESCoBraD is advancing diagnosis & treatment of brain disorders? Join our experts as they share the latest findings from this Horizon Europe project. Secure your spot today!
#HealthcareInnovation #BrainDisorders
Join us!
"Transforming Brain Disorder Care with Real-World Data: Key Insights from the MES-CoBraD Project." Don’t miss the chance to explore the future of brain disorder research with top experts! #MESCoBraD #BrainHealth
🗓️ 06/12/2024
🕒 11:00 CET
🔗 mes-cobrad.eu/Key-Insights-f…
The MES-CoBraD project is reshaping brain disorder care with real-world data! In our last event, we’ll share insights, innovations, and lessons learned. Register now! #MESCoBraD #BrainHealth
🗓️ 06/12/2024
🕒 11:00 CET
🔗 mes-cobrad.eu/Key-Insights-f…
Join us!
"Transforming Brain Disorder Care with Real-World Data: Key Insights from the MES-CoBraD Project." Don’t miss the chance to explore the future of brain disorder research with top experts! #MESCoBraD #BrainHealth
🗓️ 06/12/2024
🕒 11:00 CET
🔗 mes-cobrad.eu/Key-Insights-f…
How can real-world data & AI transform brain disorder diagnosis? Our final #MESCoBraD webinar shares 3 years of groundbreaking research in advancing patient care. Don’t miss it!
🗓️ 06/12/2024
📷 11:00 CET
🔗mes-cobrad.eu/Key-Insights-f…
#BrainHealth #DigitalHealth
Join us!
"Transforming Brain Disorder Care with Real-World Data: Key Insights from the MES-CoBraD Project." Don’t miss the chance to explore the future of brain disorder research with top experts! #MESCoBraD #BrainHealth
🗓️ 06/12/2024
🕒 11:00 CET
🔗 mes-cobrad.eu/Key-Insights-f…
MES-CoBraD, represented by @DSS_Lab and @NIOAGR, will be holding a Roundtable on “Artificial Intelligence Methods for Understanding Complex Brain Disorders” on IISA 2024, July 17-20, 2024.
easyconferences.eu/iisa2024/…
The aim is to bring together researchers with expertise relevant to the use of Artificial Intelligence (AI)/Machine Learning (ML) methods in the healthcare domain for discussing the latest advances in this emerging field.
Don't miss this opportunity to learn more about our research and innovative solutions in the fields of medical science and IT!
#ISSA2024 #medicine #neurology #IT #AI #ML #mescobrad #CoBraD #Horizon2021
H2020MESCoBraD retweeted
This study provides Class III evidence that terazosin, doxazosin, and alfuzosin use reduces the rate of developing dementia with Lewy bodies in adult men: bit.ly/4brnqpz
H2020MESCoBraD retweeted
It might be possible to treat range of neurodegenerative conditions, such as #Alzheimers, with #genetherapy that makes brain cells produce antibodies.
Tests on human mini-brains show that the antibodies can reduce levels inside brain cells of tau protein
newscientist.com/article/243…
H2020MESCoBraD retweeted
This narrative review summarizes the current understanding of poststroke epileptogenesis, risks, prognostic models, primary and secondary prophylaxis, and proposes strategies to advance the research, particularly aimed at preventing poststroke #epilepsy: bit.ly/4ci2S3W
H2020MESCoBraD retweeted
Consider anti-CD20 disease-modifying therapies as high-efficacy options in patients with MS who survive progressive multifocal leukoencephalopathy. Learn more in this Clinical/Scientific Note: bit.ly/3XmeIWg
#Neurology #NeuroTwitter
H2020MESCoBraD retweeted
The influence of #psilocybin on subconscious and conscious emotional learning
cell.com/iscience/fulltext/S… #OpenAccess @iScience_CP
H2020MESCoBraD retweeted
A study published in @iScience_CP suggests that #psilocybin does not impair learning & may enhance exploratory behavior.
The study marks the first investigation into how psilocybin influences reinforcement learning.
psypost.org/psilocybin-enhan…
Our Pilots page has been updated!
Learn more about the #mescobrad algorithms and protocols here:
mes-cobrad.eu/pilots
#medicine #neurology #IT #CoBraD #Horizon2021


















